Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional,Case-Control,Pilot Study

Abstract

Purpose

Spectral-domain optical coherence tomography (SD-OCT) was used to evaluate, in patients with multiple sclerosis without a history of optic neuritis (MSNON), the proportion of the different macular ganglion cell-inner plexiform layer complex (mGCIP) defect patterns. The results were compared with those of healthy controls (HCs).

Methods

In this cross-sectional case-control study, 34 eyes of 34 individuals, 17 with MSNON and 17 HCs, were evaluated. All participants underwent mGCIP thickness measurement using SD-OCT (Zeiss Cirrus HD-OCT 4000, macular cube protocol). The mGCIP defect patterns were classified in nine types (minimal, inner, outer, diffuse mild, diffuse severe inferior confined, inferior dominant, superior confined, and superior dominant), according to the shape derived by the deviation map of the instrument, and the proportion of each type was assessed.

Results

A mGCIP defect pattern was detected in 70.5% of MSNON eyes, with an inner type as the most frequent pattern (47%), followed by the outer type (11.7%) and the inferior confined type (11.7%). No defect was found in Hcs.

Conclusions

A significant thinning of the mGCIP with the frequent presence of an inner defect was seen in MSNON patients. The presence of this defect may serve as a biomarker of subclinical optic nerve involvement in MS patients.

Keywords

Multiple sclerosis optic nerve retinal ganglion cell retinal nerve fibre layer optical coherence tomography

Get full access to this article

View all access options for this article.

References

Koch-Henriksen

Sørensen

. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010; 9: 520–532.

Kale

. Management of optic neuritis as a clinically first event of multiple sclerosis. Curr Opin Ophthalmol 2012; 23: 472–476.

Sanders

Volkers

van der Poel

, et al. Estimation of visual function after optic neuritis: a comparison of clinical tests. Br J Ophthalmol 1986; 70: 918–924.

Ikuta

Zimmerman

. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 1976; 26: 26–28.

Toussaint

Périer

Verstappen

, et al. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 1983; 3: 211–220.

Sisto

Trojano

Vetrugno

, et al. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci 2005; 46: 1264.

Kupersmith

Nelson

Seiple

, et al. The 20/20 eye in multiple sclerosis. Neurology 1983; 33: 1015–1020.

van Diemen

HAM

Lanting

Koetsier

, et al. Evaluation of the visual system in multiple sclerosis: a comparative study of diagnostic tests. Clin Neurol Neurosurg 1992; 94: 191–195.

Kjaer

. Evoked potentials. With special reference to the diagnostic value in multiple sclerosis. Acta Neurol Scand 1983; 67: 67–89.

10.

Lanzillo

Cennamo

Criscuolo

, et al. Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis. Mult Scler 2018; 24: 1706–1714.

11.

Wang

Jia

Spain

, et al. Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis. Br J Ophthalmol 2014; 98: 1368–1373.

12.

Feucht

Maier

Lepennetier

, et al. Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis. Mult Scler 2019; 25: 224–234.

13.

Frohman

Fujimoto

Frohman

, et al. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008; 4: 664–675.

14.

Britze

Frederiksen

. Optical coherence tomography in multiple sclerosis. Eye (Lond) 2018; 32: 884–888.

15.

Cruz-Herranz

Balk

Oberwahrenbrock

, et al. The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology 2016; 86: 2303–2309.

16.

Klistorner

Sriram

Vootakuru

, et al. Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions. Neurology 2014; 82: 2165–2172.

17.

Balk

Twisk

JWR

Steenwijk

, et al.

A dam for retrograde axonal degeneration in multiple sclerosis?

J Neurol Neurosurg Psychiatry 2014; 85: 782–789.

18.

Walter

Ishikawa

Galetta

, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology 2012; 119: 1250–1257.

19.

Oberwahrenbrock

Schippling

Ringelstein

, et al. Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int 2012; 2012: 530305.

20.

Bock

Brandt

Dörr

, et al. Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clin Neurol Neurosurg 2010; 112: 647–652.

21.

Fisher

Jacobs

Markowitz

, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113: 324–332.

22.

Sepulcre

Murie-Fernandez

Salinas-Alaman

, et al. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68: 1488–1494.

23.

Knier

Schmidt

Aly

, et al. Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain 2016; 139: 2855–2863.

24.

Albrecht

Ringelstein

Müller

, et al. Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 2012; 18: 1422–1429.

25.

Knier

Berthele

Buck

, et al. Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination. Mult Scler 2016; 22: 893–900.

26.

Pietroboni

Dell’Arti

Caprioli

, et al. The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler 2019; 25: 31–38.

27.

Balk

Cruz-Herranz

Albrecht

, et al. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol 2016; 263: 1323–1331.

28.

Garcia-Martin

Ara

Martin

, et al. Retinal and optic nerve degeneration in patients with multiple sclerosis followed up for 5 years. Ophthalmology 2017; 124: 688–696.

29.

Narayanan

Cheng

Bonem

, et al. Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Mult Scler 2014; 20: 1331–1341.

30.

Sriram

Wang

Yiannikas

, et al. Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients. PLoS One 2014; 9: e102546.

31.

Syc

Saidha

Newsome

, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 2012; 135: 521–533.

32.

Hokazono

Raza

Oyamada

, et al. Pattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetry. Doc Ophthalmol 2013; 127: 201–215.

33.

Petzold

Balcer

Calabresi

, et al. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 2017; 16: 797–812.

34.

Shi

Jiang

Gameiro

, et al. Visual function and disability are associated with focal thickness reduction of the ganglion cell-inner plexiform layer in patients with multiple sclerosis. Invest Ophthalmol Vis Sci 2019; 60: 1213.

35.

Garcia-Martin

Ortiz

Boquete

, et al. Early diagnosis of multiple sclerosis by OCT analysis using Cohen’s d method and a neural network as classifier. Comput Biol Med 2021; 129: 104165.

36.

Lublin

. New multiple sclerosis phenotypic classification. Eur Neurol 2014; 72: 1–5.

37.

Thompson

Banwell

Barkhof

, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology 2018; 17: 162–173.

38.

Tewarie

Balk

Costello

, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. Villoslada P, editor. PLoS ONE 2012; 7: e34823.

39.

Jeong

Kang

Kim

, et al. Pattern of macular ganglion cell-inner plexiform layer defect generated by spectral-domain OCT in glaucoma patients and normal subjects. J Glaucoma 2015; 24: 583–590.

40.

Lee

J-Y

Choi

Park

K-A

, et al. Ganglion cell layer and inner plexiform layer as predictors of vision recovery in ethambutol-induced optic neuropathy: a longitudinal OCT analysis. Invest Ophthalmol Vis Sci 2018; 59: 2104.

41.

Lee

Kim

, et al. Temporal raphe sign for discrimination of glaucoma from optic neuropathy in eyes with macular ganglion cell–inner plexiform layer thinning. Ophthalmology 2019; 126: 1131–1139.

42.

Sharifipour

Morales

Lee

, et al. Vertical macular asymmetry measures derived from SD-OCT for detection of early glaucoma. Invest Ophthalmol Vis Sci 2017; 58: 4310–4317.

43.

Chen

M-J

Yang

H-Y

Chang

Y-F

, et al. Diagnostic ability of macular ganglion cell asymmetry in preperimetric glaucoma. BMC Ophthalmol 2019; 19: 12.

44.

Shin

Sung

Park

S-W

. Patterns of progressive ganglion cell–inner plexiform layer thinning in glaucoma detected by OCT. Ophthalmology 2018; 125: 1515–1525.

45.

Yum

Park

H-YL

, et al. Macular ganglion cell analysis determined by cirrus HD optical coherence tomography for early detecting chiasmal compression. Narayanan R, editor. PLoS ONE 2016; 11: e0153064.

46.

Balducci

Savini

Cascavilla

, et al. Macular nerve fibre and ganglion cell layer changes in acute leber’s hereditary optic neuropathy. Br J Ophthalmol 2016; 100: 1232–1237.

47.

Shao

Jiang

Wei

, et al. Visualization of focal thinning of the ganglion cell–inner plexiform layer in patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2018; 64: 1261–1273.

48.

Cheung

Ong

Hilal

, et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2015; 45: 45–56.

49.

Jiang

Gameiro

, et al. Focal thickness reduction of the ganglion cell-inner plexiform layer best discriminates prior optic neuritis in patients with multiple sclerosis. Invest Ophthalmol Vis Sci 2019; 60: 4257.

50.

Hood

Raza

de Moraes

CGV

, et al. Glaucomatous damage of the macula. Prog Retin Eye Res 2013; 32: 1–21.

51.

Saidha

Syc

Durbin

, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 2011; 17: 1449–1463.

52.

Abalo-Lojo

Limeres

Gómez

, et al. Retinal nerve fiber layer thickness, brain atrophy, and disability in multiple sclerosis patients. J Neuroophthalmol 2014; 34: 23–28.

53.

Tátrai

Simó

Iljicsov

, et al. In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosis. Villoslada P, editor. PLoS ONE 2012; 7: e30922.

54.

Saidha

Sotirchos

, et al. Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol 2013; 70: 34–43.

55.

Coric

Balk

Verrijp

, et al. Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers. Mult Scler 2018; 24: 158–166.

56.

Zimmermann

Knier

Oberwahrenbrock

, et al. Association of retinal ganglion cell layer thickness with future disease activity in patients with clinically isolated syndrome. JAMA Neurol 2018; 75: 1071.

57.

Hanson

JVM

Wicki

Manogaran

, et al. OCT And multiple sclerosis. In: Grzybowski

Barboni

(eds) OCT And imaging in central nervous system diseases [Internet]. Cham: Springer International Publishing, 2020. [cited 2020 Dec 3]. p. 195–233. Available from: http://link.springer.com/10.1007/978-3-030-26269-3_11